INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
SEC FORM 4/Grant or awardVerified data

Angle Siddhesh Rajendra reported BBLG

Director · Bone Biologics Corp · Bone Biologics Corp — Non-Employee Stock Option

Side
A
Value
—
Shares
113.9K
Price
—
Executed
Sep 28, 2026
Disclosed
Sep 30, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Sep 28 executedSep 30, 2026 disclosed

BBLG · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · BBLG

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    GE
    Gagnon Robert E.Director
    BBLGBone Biologics Corp
    Grant or award
    		A—
    113.9K sh
    		Sep 28, 2026Sep 30, 2026
    traded Sep 28, 2026
    		+2dSEC FORM 4

    Evidence

    9
    MT
    Meikle Phillip Terry IIDirector
    BBLGBone Biologics Corp
    Grant or award
    		A—
    113.9K sh
    		Sep 28, 2026Sep 30, 2026
    traded Sep 28, 2026
    		+2dSEC FORM 4

    Evidence

    9
    SB
    Stroever BruceDirector
    BBLGBone Biologics Corp
    Grant or award
    		A—
    113.9K sh
    		Sep 28, 2026Sep 30, 2026
    traded Sep 28, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001493152-26-045147
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Sep 28, 2026
    Published
    Sep 30, 2026
    Ingested by INSIDER
    Nov 5, 02:14 UTC
    Last re-read
    Nov 5, 02:14 UTC

    Extracted facts

    Filer
    Angle Siddhesh Rajendra
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Bone Biologics Corp — Non-Employee Stock Option
    Ticker
    BBLG
    Shares
    113.9K
    Price per share
    $0
    Execution date (reported)
    Sep 28, 2026
    Owned after transaction
    113.9K shares
    Days from execution to publication
    2

    What this establishes

    Angle Siddhesh Rajendra filed this Form 4 reporting a grant or award of BBLG on Sep 28, 2026. It became public on Sep 30, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Angle Siddhesh Rajendracik:0001889218
    Issuer
    Bone Biologics Corpcik:0001419554

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.